top of page

From Laboratory to Commercial Supply: Scaling Botanical EVs

Oct 7
1 min read

A recurring bottleneck in advanced biotechnology research is moving an innovation from a controlled laboratory environment into scalable commercial production. The World Exosome Center represents an industrial production and scale-up infrastructure specifically designed to bridge the gap between laboratory isolation and repeatable B2B ingredient production. The facility is built to deliver a reproducible botanical platform, rather than just milligrams of experimental EV ingredient supply.  



True commercial viability also requires practical handling and storage solutions. Building on years of production and process-development experience, AYE Exocure has engineered source- and application-specific stabilization workflows.   

  • Extended Shelf Life: For selected preparations, accelerated stability studies under defined conditions support a projected room-temperature shelf life of up to 24 months.   

  • Logistical Efficiency: This extended room-temperature stability significantly reduces the industry's dependence on specialized, highly regulated cold-chain logistics.   

  • Standardized Production: Throughout scale-up, critical quality attributes—such as product consistency and maintaining particles within a defined nanoscale range below 200 nm—are strictly monitored to ensure reproducible production across batches.   

To further support B2B assessment, qualification, and supply, all production is backed by a robust quality framework that includes ISO 9001:2015, ISO 22716 GMP, Vegan Certification, and FDA compliance.   


 
 
bottom of page